|
ABOUT COMPANY
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company is headquartered in New York, New York.
|
EARNINGS
Gross Profit (TTM): -35203000
Market Capitalization: 72501000
Operating Margin (TTM): -3.795
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.628
Revenue (TTM): 19716000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -0.041
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.133
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -30286000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|